z-logo
Premium
Ventricular tachycardia oversensing in S‐ICD patients: Case‐based brief review
Author(s) -
Zoppo Franco,
Mangiameli Daniele,
Perazza Luca,
Lardieri Gerardina
Publication year - 2020
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/pace.13871
Subject(s) - medicine , cardiology , implantable cardioverter defibrillator , amiodarone , ventricular tachycardia , ejection fraction , ventricular fibrillation , shock (circulatory) , atrial fibrillation , tachycardia , heart failure
A 76‐year‐old woman with permanent atrial fibrillation and a mechanical aortic valve came to our attention. Echocardiography showed a 50‐55% ejection fraction (EF) with good prosthesis performance. For symptomatic bradyarrhythmia, she received a VVI pacemaker (Proponent MRI L2010 model; Boston Scientific.). During follow‐up, frequent symptomatic (presyncopal) episodes of nonsustained episodes of ventricular tachycardia (VT) were detected. Amiodarone proved unsuccessful; she was then offered an upgrade to an implantable cardioverter defibrillator (ICD) and a subcutaneous ICD (S‐ICD) was chosen by the patient. A few weeks later, two sustained VT were detected and effectively treated with 80‐J shock delivery. In both cases, device interrogation revealed a VT rate around 163 bpm (370 ms cycle length), below the lowest device detection cutoff. The report is a case‐based review.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom